| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.001 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.00033 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.00035 | 1 |